Blokhin's Russian Cancer Research Center
Clinical trials sponsored by Blokhin's Russian Cancer Research Center, explained in plain language.
-
Could a common mental health drug prevent weight loss in cancer patients?
Symptom relief Recruiting nowThis study is testing whether a low dose of olanzapine, a drug usually used for mental health conditions, can prevent or treat the loss of appetite and weight that often happens in cancer patients receiving chemotherapy. About 100 adults with stomach or ovarian cancer will take t…
Phase: PHASE3 • Sponsor: Blokhin's Russian Cancer Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Scientists probe genetic changes when GI cancers spread to brain
Knowledge-focused Recruiting nowThis study looks at tissue samples from 30 adults with stomach or esophageal cancer that spread to the brain. Researchers compare the genetic markers of the original tumor and the brain tumor to see if they differ. The goal is to better understand how these cancers change when th…
Sponsor: Blokhin's Russian Cancer Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New study checks how well a targeted breast cancer drug works in russian patients
Knowledge-focused Recruiting nowThis study will look at medical records of 60 Russian patients with advanced HER2-positive breast cancer who have received trastuzumab deruxtecan. Researchers want to see how long the drug keeps cancer from growing and how safe it is. The goal is to understand how well this treat…
Phase: NA • Sponsor: Blokhin's Russian Cancer Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC